an Istitution Experience on Parosteal OsTeosarcoma

Istituto Ortopedico Rizzoli220 enrolled

Overview

single institution cases series review of histological and clinical data

Investigators will review all the cases with a diagnosis of primary parosteal osteosarcoma treated at the Rizzoli Institute from 1900 up to 31 July 2018, retrospectively.

Study Type

OBSERVATIONAL

Enrollment

220

Conditions

Parosteal Osteosarcoma

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Male and female patients treated at Rizzoli Institute from 01 Jan 1900 to 31 Jul 2018 * Diagnosis of parosteal osteosarcoma * Written informed consent prior to any study-specific analysis and/or data collection Exclusion Criteria: • Patients with histological diagnosis different from parosteal osteosarcoma

Locations (1)

Istituto ortopedico Rizzoli

Bologna, Italy

Outcomes

Primary Outcomes

retrospective analysis of cases of Parosteal osteosarcoma

Investigators will exam the presence of progression (dedifferentiation) areas and the relationship of these factors to individual outcome.

Time frame: at baseline (Day0)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.